Rheumatic diseases: the effects of inflammation on bone.
about
Refining the Management of Rheumatoid Arthritis: the Benefits of Subcutaneous TocilizumabEvolutionary medicine and bone loss in chronic inflammatory diseases--A theory of inflammation-related osteopeniaAnti-IL-20 monoclonal antibody inhibits the differentiation of osteoclasts and protects against osteoporotic bone lossPhospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizationsOrganic dust, lipopolysaccharide, and peptidoglycan inhalant exposures result in bone loss/diseaseAnti-citrullinated protein antibodies are associated with decreased bone mineral density: baseline data from a register of early arthritis patients.Phospholipase C gamma 2 is critical for development of a murine model of inflammatory arthritis by affecting actin dynamics in dendritic cells.Hand bone mineral density is associated with both total hip and lumbar spine bone mineral density in post-menopausal women with RA.Effect of Trichilia monadelpha (Meliaceae) extracts on bone histomorphology in complete Freund's adjuvant-induced arthritis.Transcriptional regulation of bone and joint remodeling by NFATRisk factors for radiographic progression in psoriatic arthritis: subanalysis of the randomized controlled trial ADEPT.Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis.Potential of resveratrol analogues as antagonists of osteoclasts and promoters of osteoblasts.Anti-inflammatory effect of sargachromanol G isolated from Sargassum siliquastrum in RAW 264.7 cells.TRAF-6 dependent signaling pathway is essential for TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiationVav/Phospholipase Cgamma2-mediated control of a neutrophil-dependent murine model of rheumatoid arthritis.Early effects of tumor necrosis factor inhibition on bone homeostasis after soluble tumor necrosis factor receptor useDirect inhibition of human RANK+ osteoclast precursors identifies a homeostatic function of IL-1beta.Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice.Role of periodontal pathogenic bacteria in RANKL-mediated bone destruction in periodontal disease.Hand bone mass in rheumatoid arthritis: A review of the literatureInactivation of DAP12 in PMN inhibits TREM1-mediated activation in rheumatoid arthritisSkeletal health of children and adolescents with inflammatory bowel disease.Quantifying not only bone loss, but also soft tissue swelling, in a murine inflammatory arthritis model using micro-computed tomographyConstitutive activation of IKK2/NF-κB impairs osteogenesis and skeletal development.B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal diseaseThe impact of inflammation on bone mass in children.CCN1 induces oncostatin M production in osteoblasts via integrin-dependent signal pathwaysRheumatoid arthritis is associated with less optimal hip structural geometryIdentification of a human peripheral blood monocyte subset that differentiates into osteoclasts.Early changes in bone mineral density measured by digital X-ray radiogrammetry predict up to 20 years radiological outcome in rheumatoid arthritisGlucocorticoids and tumor necrosis factor α increase oxidative stress and suppress Wnt protein signaling in osteoblastsSoluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients.Morphological characterization of intra-articular HMGB1 expression during the course of collagen-induced arthritis.Depletion of regulatory T cells leads to an exacerbation of delayed-type hypersensitivity arthritis in C57BL/6 mice that can be counteracted by IL-17 blockade.The role of interleukin 6 in the pathophysiology of rheumatoid arthritisIonizing Radiation and Bone Loss: Space Exploration and Clinical Therapy ApplicationsRevealing cytokine-induced changes in the extracellular matrix with secondary ion mass spectrometryRANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritisProteinases in the joint: clinical relevance of proteinases in joint destruction
P2860
Q28080677-70DB9E79-5222-458E-A4E1-089AB9456380Q28088695-14AC480C-A727-42E5-A15A-34F70C3BB131Q28245637-5F2C09B4-D074-475D-8231-5C5AEB770728Q28286551-2165C755-B442-46AB-B943-B01BEC94FAC3Q28396417-A5757C01-F61A-42C1-912C-C80D5995C40DQ31167745-1CBF281A-09BB-4175-A290-C6E8B140B899Q33527426-FE70C535-0EE9-41DC-A095-7721AB2E8AB8Q33646329-81FD9A6A-2F81-4BD3-96E5-1396F7BD4B31Q33675572-D90844B3-EEC5-432B-8848-1EB14D86A62AQ33998768-B5EC2EA5-1B5B-4F6B-A7FE-76CF21CEE1CDQ34027596-9F2D3207-8135-40B2-90BC-A137BEAEE0D6Q34059280-067973AF-4008-409F-A6F0-988031BACAA7Q34242787-78DE06BA-2706-4DE5-9F24-02E63A7CB018Q34297129-2398285F-E382-43AD-9B04-F994C1840241Q34311797-492A59F1-F05D-4EF7-AD74-9C8BED76B94CQ34419714-76E3FF40-E487-45A1-93CC-B8FBA77339FDQ34451418-26A653BA-4696-47FD-9E13-1B7100464B65Q34467768-E43DCC85-601E-46CF-910C-596B2A1ACF0FQ34488033-736E3123-25F6-4722-9A84-BBFFFCF9E723Q34886943-ED5B5ED1-1B56-4CA8-84E0-8C4A9E0AA04FQ35003427-6FA92E6A-334A-4B21-BD01-4579A1A71AB3Q35038322-8F7F5B15-DAE6-4A7C-A6E4-6DAE568B439AQ35065044-B046E737-23C3-46B8-A611-518971AFC14AQ35086184-EE968157-53B6-4249-A758-57255ED7FD10Q35117972-A816D508-7432-46E4-95A9-F3A84E490559Q35222008-6410939B-303A-4EA9-AEA4-BC9E79CC2BC5Q35226354-5F173F1C-E904-4E44-82D3-469FB9BB07A4Q35238090-2ACFDE1F-8366-43E5-A4F1-72CD9A306A51Q35566318-2104830B-3AFF-400E-BDE8-74B4DD645AF0Q35605683-E39F8332-40A8-40EB-BDE9-51BFE327FCF5Q35620364-AD24C311-C519-42B5-BDAB-3F45ECA63BFCQ35639657-1DC28EE3-4C61-4105-B456-8EEFCBA60D6EQ35840828-ACE9412E-395F-48AE-9CF4-A709A8F4E931Q35869016-325BC334-8C1E-48CE-8BBD-8F0316E41093Q35907743-5372C1F3-D131-4203-9AA8-78C4E9776EF1Q36059484-EA255CB1-BB02-45A7-8728-72B6E20E1AC3Q36107070-E8FADCE8-16C3-44B3-A566-3C22ADE85E3BQ36199105-73FF8D8D-1FE2-444B-B73E-BEC134185F92Q36246148-244D1999-1DC4-4110-AE6A-D73CEBA3517FQ36401848-FB65EEF5-7DAF-48F0-A396-7B12B672B7FD
P2860
Rheumatic diseases: the effects of inflammation on bone.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Rheumatic diseases: the effects of inflammation on bone.
@ast
Rheumatic diseases: the effects of inflammation on bone.
@en
type
label
Rheumatic diseases: the effects of inflammation on bone.
@ast
Rheumatic diseases: the effects of inflammation on bone.
@en
prefLabel
Rheumatic diseases: the effects of inflammation on bone.
@ast
Rheumatic diseases: the effects of inflammation on bone.
@en
P2093
P2860
P1476
Rheumatic diseases: the effects of inflammation on bone.
@en
P2093
Ellen M Gravallese
Nicole C Walsh
Steven R Goldring
Tania N Crotti
P2860
P304
P356
10.1111/J.0105-2896.2005.00338.X
P577
2005-12-01T00:00:00Z